The Efficacy and Safety of DLBS3233 in Adults With Prediabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT07937449

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07937449
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Indonesia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07937449. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-07 (actual); primary completion 2026-10-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy and Safety of DLBS3233 in Adults With Prediabetes
Condition
Prediabetes
Intervention (Drug)
DLBS3233
Intervention (Drug)
Metformin XR
Lead sponsor
Dexa Medica Group (class: industry)
Collaborator
PT Equilab International (class: industry)

Record details

Record id
cardio:ct-nct07937449
Content hash
df26dfc6d26a1057bebeab4a20514452dfe2451a54d95669be7d801040674497